| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K29086754 |
| PharmacoGx | BRD-K29086754 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LYPD2 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | PPIE | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | AK6 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.03 |
| mRNA | PACRGL | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | USP30 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | AC006994.3 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | SYNJ2BP-COX16 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.03 |
| mRNA | SLCO2A1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | SHOC2 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | FAM159A | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
